Complete Remission: Evaluation of the Complete Remission Rates in Patients With Symptomatic Non-erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (GERD) Treated With Pantoprazole 40 Milligram o.d. Over 4 or 8 or 12 Weeks.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 04 May 2012 Company added to the associations field as reported by ClinicalTrials.gov record.
- 05 Nov 2005 New trial record.